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Variability among individual T  cell receptor Ti ~ and/3 subunits results from 
germline diversity of variable, diversity, and joining (V, D, and J)-like elements 
that  encode  them  and  from  combinatorial  events  linking  these  discontiguous 
gene segments during ontogeny (1-3).  To examine the rules governing Ti/3 V 
gene  usage  in  formation  of T  cell  antigen/major  histocompatibility  complex 
(MHC) receptors of individual T  cell subpopulations, we developed and charac- 
terized a monoclonal antibody directed against a specific epitope on products of 
one  prototypic  Ti  13  gene  family,  REX  (4).  The  REX  V  gene  products  are 
expressed on 2% of unprimed peripheral T  cells of all human beings and are not 
restricted  to  either  T4 + or  T8 + subpopulations.  Southern  analysis,  isoelectric 
focusing, and two-dimensional peptide mapping of a wide range of T  cell clones 
indicated that each REX  V  gene could form a  linkage to different Ti/3 D and/ 
or J  segments.  Moreover,  the  Ti  a  chains  of such  clones  were  distinct.  This 
implies that Ti/3 V gene usage is not restricted to functionally or phenotypically 
defined subsets  and  that  there  is  presumably  little  restriction  on  mechanisms 
generating combinatorial, junctional, or chain association-mediated diversity. 
Materials and Methods 
Derivation of Lymphoid Populations and T Cell Clones.  Mononuclear cells were rosetted 
with sheep erythrocytes, and the  E  ÷ fraction was  incubated with anti-Ti~A monoclonal 
antibody (mAb) (100 #1 ofa 1:250 dilution per 106 T cells) for 30 min at room temperature. 
Subsequently, anti-Ti3A-reactive cells (Ti~A+) were separated from anti-Ti~A-nonreactive 
cells (Ti3A-) by indirect rosetting with ox erythrocytes (5). The anti-Ti~A* cells obtained 
(~70% Ti3A+) were then stimulated with the irradiated (5,000 rad) B lymphob]astoid line 
Laz 509 at a T  cell/Laz 509 ratio of 1:1 in RPMI  1640 containing 5,000-rad-irradiated 
feeder cells  (0.5  ×  106  autologous whole  mononuclear cells/ml).  After  1 wk  in  vitro 
culture at 37 °C, activated cells were reacted with anti-Ti3a mAb, stained with goat anti- 
mouse F(ab')2 fluorescein isothiocyanate (FITC), and sorted on an  Epics  V  cell sorter 
(Coulter Electronics, Inc., Hialeah, FL) using the autoclone method (4). For this purpose, 
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TABLE  I 
Specificity Analysis of Ti:~a+ Cytotoxic T Lymphocytes Clones 
Target cell lysed 
(:lone  Phenotype  Allospecificity 
L509  L156  L503  L467  L468  L471  L475  S002 
AA2  T3+T4-T8 +  +  .......  II  SB. 
AA6  T3+T4-T8 +  +  ......  ND  I  NA 
AA8  T3+T4+T8 -  +  .......  ll  Dr7p or 4p 
AA9  T3+T4-T8 ÷  +  .......  I1  Dr7p or 4p 
AA13  T3*T4-T8 +  +  ......  +  l  HLA-BI 3 
AAl4  T3+T4-T8 ÷  +  -  +  -  -  +  +  ND  I  HLA-A2(sub) 
AA18  T3+T4+T8 -  +  .......  II  Dr7p or 4p 
(:P4  T3+T4+T8 -  +  -  -  +  -  +  -  ND  ll  SBy 
CP6  T3+T4-T8 +  +  -  -  -  +  -  -  -  1  HLA-A25 
CPI0  T3+T4-T8 +  +  +  +  +  +  -  -  ND  I  NA 
(:lones AA and CP were derived fi'om two separate donors.  MHC genotypes for individual B  lymphoblastoid lines 
are as f~llows.  Laz 509:  A2, A25,  B13,  Bw38,  DR4,  DR7,  Laz  156:  A2, A3, B7,  B40,  DR2,  DR4;  Laz 503:  A2, 
B27,  DR6;  Laz 467:  A3,  All,  BI5,  Bw35,  DR1;  Laz 468: A25,  B18,  DR2;  Laz 471:  A2, Bw44,  DR7;  Laz 475: 
A2. A9, Bw44, B40,  DR5; and cell SEL002: A1, A2, BI3, B40, Bw4, Bw6, DR2, DR7,  DRw53. Donor AA is A3, 
B35, Bw6, Cw4, DR2, DR4, DRw53, Dqwl, Dqw3 and donor CP is A2, BI4, B44, Bw4, Bw6, DR4, DR7, DRw53, 
Dq~2,  Dqw3. Antibody blocking studies were performed as described in Materials and Methods and in the legend 
to  Fig.  I.  1,  MHC  class  l;  II, MHC  class  II. (-) _<5%  specific  lysis; (+) >30%  specific  lysis, at a  10:1  E/T  ratio. 
AIlospecificity assignment is based on the present panel analysis and the testing of 10 additional B  lymphoblastoid 
lines. SB~ and SBy signify unknown presumptive SB specificities; Dr7p or Dr4p denotes private Dr specificities, and 
HLA-A2 (sub), a  subset of HLA-A2 molecules. NA, not assignable.  ND, not done. 
cells were cloned directly into 96-well microtiter plates (Rochester Scientific Co., Roch- 
ester, NY) at 1 cell per well, into which were placed 50,000 autologous irradiated feeders 
per well, 20,000 irradiated Laz 509 per well, and 10% (vol/vol) IL-2. 
Functional  T Cell Assays and mAb.  The cytotoxicity assay was a standard 4 h killing 
system using 5~Cr-labeled B lymphoblastoid cell lines in which effector/target ratios were 
40:1,20:1, 10:1, and 1  : 1 (6). For antibody blocking studies, a 1:250 dilution of hybridoma 
ascites containing anti-T8, anti-T4, anti-BT3.4, anti-BT2.9, anti-PTF29, anti-W6/32, or 
anti-TisA was used (6-9). Anti-Ti~A was recently shown (4) to identify an epitope on the 
V gene product of members of the REX V gene family. 
Results and Discussion 
To examine the potential diversity of specificities among T  lymphocyte anti- 
gen/MHC receptors using a single Ti fl V gene set, we characterized allospecific- 
tries of cytotoxic T  lymphocyte (CTL) clones expressing a  prqduct of the REX 
Ti ¢3 V gene family. Resting peripheral blood T  lympbocytes were first identified 
and separated with mAb anti-Ti3A, directed at an epitope on the products of the 
REX  V  gene  family (~2%  of total  T  lymphocytes) (4)  and then stimulated in 
vitro with the allogeneic B lymphoblastoid line, Laz 509. The alloreactive Ti3A+ 
T  lymphocytes were cloned by micromanipulation and the specificity of clones 
for the stimulating Laz 509 line verified in mixed lymphocyte culture and/or by 
cell-mediated lympholysis. We obtained 27 anti-Ti.~A-reactive, Laz 509-allospe- 
cific clones derived from three unrelated donors. 10 of these 27 clones manifested 
cytotoxic effector function and are the subject of the present report. 
To estimate the number of specificities encoded by the alloreactive Ti~a÷ CTL 
clones, we assembled a panel of Epstein-Barr virus (EBV)-transformed B lympho- 
blastoid target cells expressing known class I and class II MHC specificities and 
determined the pattern of killing by individual clones. As shown in Table I, even 
without examining the serologically defined allodeterminants of the individual 
target  cells,  a  minimum  of  six  distinct  clonal  specificities  was  defined.  For 
example,  clones AA2,  AA6,  AA8,  and  AA9,  AA18  were  selectively cytotoxic ACUTO ET  AL.  BRIEF  DEFINITIVE REPORT  1389 
for the B lymphoblastoid line Laz 509, but for none of the other seven target 
cells in this panel. In contrast, the other CTL clones killed Laz 509 and one or 
more different target cells.  Thus,  AA13  killed cell  SEL002; AA14  killed Laz 
503,  Laz 471, and  Laz 475; CP4  killed Laz 467  and Laz 471;  CP6 killed Laz 
468; and CP10 killed Laz 156, Laz 503, Laz 467, and Laz 468. 
The class  of the target  cell  MHC  molecules recognized by individual CTL 
clones was examined by antibody blocking studies.  For this purpose,  Laz 509 
was preincubated in parallel with either the W6/32 mAb directed at a framework 
determinant on the HLA c~ chain of A, B, and C  loci or mAb directed against 
class  II  MHC  gene  products.  The  latter  included  antibody  PTF29  directed 
against a  monomorphic epitope  on  DR  molecules,  the  mAb  BT2.9  directed 
against a monomorphic region of both DR and SB gene products, and the mAb 
BT3.4 directed against a polymorphic DC epitope (related to DC 1) expressed by 
Laz 509  (7-9).  Such analysis of putative class  II specificities with these anti-Ia 
antibodies provisionally allows for localization of specificities to a gene product 
of one of the three MHC class II subloci. 
A  composite of the antibody blocking data  is  provided in  Table  I  and  the 
representative experimental data that resulted in the assignments is depicted in 
Fig. I. For example (Fig.  1A), it is evident that the T4 ÷ clone AA18 is directed 
against a class II MHC molecule. The anti-HLA antibody failed to block specific 
cytotoxicity whereas the anti-DR-specific mAb PTF29 inhibited specific killing 
by 91% and mAb BT2.9 inhibited killing by 41%. Note that these effects cannot 
be nonspecific because,  unlike the other anti-class II antibodies, the anti-DC1 
antibody BT3.4 did not block killing function. On the other hand, the T8 + clone 
AA6 was blocked in  an  altogether different pattern,  consistent with a  class  I 
clonal specificity (Fig. 1B). In this case, anti-HLA antibody inhibited cytotoxicity 
by 87%  while all three of the anti-Ia antibodies blocked cytotoxicity by <6%. 
Fig.  1 C shows yet another different pattern, with the T8 + clone AA9. Because 
this clone is inhibited by anti-BT2.9 and anti-PTF29 antibody and not by anti- 
HLA, it has been assigned a  class  II specificity. Nevertheless, the inhibition is 
distinct from the class II-specific Tia÷ clone AA 18, in that AA9 was equally well 
inhibited by BT2.9 and  PTF29.  These results suggest that, while both clones 
recognize epitopes on DR molecules, the epitopes are distinct from one another. 
The collective data (Table I) indicate that five CTL clones are directed at class 
II and five CTL clones at class I MHC gene products. 
To relate the specificity of individual T  cell  clones resulting in lysis of select 
target cells to known serologically defined histocompatibility types, we examined 
the class  I and II MHC type of each target cell  in the panel.  Furthermore, the 
panel analysis shown in Table I was extended to 10 more B lymphoblastoid lines 
of known genotype (not shown). Specificities in Table I (right-hand column) were 
assigned on the basis of individual B lymphoblastoid lines sharing a known MHC 
allele to serve as targets for a  given clone. Results were always consistent with 
the class of MHC target molecule defined by the mAb blocking studies in Fig. 1. 
While there was often no precise correlation between serologically defined HLA 
specificities and T  cell clone allospecificities, this was not unexpected given the 
possibility that there are differences in epitopes recognized by antibodies and T 
cell receptors and the monoclonality  of the T cell populations vs. the polyclonality 
of alloantibodies used.  Thus,  clones AA6 and CP10  could not be assigned to 1390  ACUTO  ET  AL.  BRIEF  DEFINITIVE  REPORT  °°]l[[ 
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FIC,  URE  ].  Inhibition of lyric function  of various Ti3A+ CTL clones by mAb directed at T 
cell surface structures or MHC gene products. Percent inhibition of Laz 509 killing is noted 
on the ordinate for the T4  + clone AA|8  (A); the T8  + clone AA6 (B); and the T8  + done AA9 
(C).  51Cr release from  Laz  509  was  as  follows:  maximal release,  ],966  cpm;  spontaneous 
release,  215 cpm; and AA 18-induced release,  950 cpm in the absence of antibodies.  Results 
are representative of similar values obtained for clones in B and C (E/T ratio,  10:1). 
known class I determinants, and clone AA 14 recognized only a subset of HLA- 
A2 molecules. Nevertheless, this analysis indicated that clone AA13 is directed 
at HLA-B13, and clone CP6 at HLA-A25. In addition, three clones, AA8, AA9, 
and AA 18, appear to be directed at private DR7 or DR4 determinants expressed 
only on  the  Laz 509  line.  These three clones are distinct from one another, 
however, since the restriction pattern of REX V genes in Southern analysis was 
different in  each  (not  shown).  Whether  this  indicates  that  several  different 
antigen/MHC receptor moleeules may give rise to the same private specificity or 
that such T  cell receptor molecules view different private epitopes on the DR7 
or DR4 molecules of Laz 509, is not presently known. Even in the absence of SB 
typing,  it  is  likely  that  T  cell  clones  AA2  and  CT4  recognized  distinct  SB 
determinants as judged by the ability of BT2.9 mAb to inhibit killing of these 
clones better than PTF29 (83-96%  vs. 21-55%) and, in the case of CP4, to kill 
homozygous DR typing cells lacking related DR alleles. The present data imply 
that the REX Ti/3 V genes can be used to generate both class I and II specificities, 
and that multiple MHC specificities can be generated against each of these MHC 
gene products. 
It was previously suggested (10) that the antigen binding structure for nominal 
antigen  and  polymorphic MHC  is  the  Ti  glycoprotein and  that  T8  and  T4 
function as ancillary recognition elements which bind to invariant epitopes of 
class  I or II molecules, respectively. One prediction from this model is that the ACUTO ET  AL.  BRIEF  DEFINITIVE REPORT  1391 
T3-Ti  complexes of T4 + and  T8 + T  lymphocytes are  fundamentally  similar. 
Class II and class I  MHC preferences of T4 + and T8 + clones are consequences 
of the  ability of T4 ÷ clones to  bind  class  II  and  nominal  antigen  "X"  on  the 
stimulating  cell  more  efficiently than  T8 ÷ clones  (and  vice  versa  for  class  I- 
nominal  antigen  X  molecules)  during  the  primary  immune  response.  On  the 
other hand,  clones with intrinsically high affinity T3-Ti complexes that viewed 
class II-X or class I-X directly would not use the ancillary T4 and T8 molecules. 
The  experimental  results  herein  with  the  T8 +  clones  AA6  and  AA9  are 
consistent  with  this  prediction.  Thus,  whereas  the  T8 +  MHC  class  I-specific 
clone AA6 was inhibited  by anti-T8  and  not anti-T4  antibody, the  MHC class 
II-specific T8 + clone AA9 was inhibited neither by anti-T8 nor anti-T4 antibody. 
Moreover, the antigen/MHC receptor antibody anti-Ti3A  virtually abrogated the 
cytotoxic effector function of clone AA6 but only inhibited  the CTL effector 
function of AA9 by 65%.  Titrationai  analysis (not shown) indicates clearly that 
AA6  is  inhibited  using  approximately  one  order  of magnitude  less  anti-Ti3a 
antibody.  These  results  suggest  that  the  T3-Ti  complex  of AA6  is  of lower 
affinity  than  that  of AA9,  even  though  both  employ  a  REX  Ti  /3  V  gene. 
Consequently, the former requires the T8 ancillary recognition structure. 
If both class II and I specificities can be generated from T  cell clones by using 
a  single set of highly  homologous Ti  /3 V  genes,  what is the basis upon which 
unique  Ti  domains  encoding  multiple  and  distinct  specificities are  generated? 
This  question  must  be addressed  in  light  of the  lack of evidence  for  somatic 
mutation in T  cell receptor V genes and a growing body of data indicating that 
the number of germline  V  genes encoding the Ti/3 subunit is small relative to 
the number of IgH V genes (4). It is likely, therefore, that combinatorial diversity 
created by association of different gene segments during active V gene formation 
within the Ti/3 subunit (including at least 2 possible D segments and  12 possible 
J  segments,  6 J/31,  and 6 J/32 segments) is in large part responsible for receptor 
repertoire  generation.  The  fact that  recombination  sequences allow for direct 
v-J joining as well as V to multiple D and J joining,  uniquely in T  cells, further 
supports  this  view  (3).  In  addition,  junctional  diversity  would  be  created  by 
variations  in  the joining  sites  of  these  gene  segments.  Moreover,  extensive 
diversity would be created by combinatorial and junctional mechanisms in Ti 
subunits  as  well.  The  latter  subunit  appears  to  be encoded by a  substantially 
larger  number of V  and J  gene segments (L.  Hood, personal  communication). 
Finally, association-mediated diversity resulting from assembly of different Ti 
and/3 V region polypeptides would amplify diversity. 
In conclusion, the present data show that a single set of highly related Ti/3 V 
genes can  give rise  to multiple  T  lymphocyte receptors with  class  I  as  well as 
class II specificities. The sequences of V/3 cDNAs isolated from several murine 
T  cell clones of different specificities are also consistent with the present findings 
(11, 12). While not enough is known about the structural basis of T  cell receptor 
antigen  recognition or fine specificities of a  large number of T  cell clones using 
a prototypic Ti/3 V gene, it is tempting to speculate that at least certain different 
allospecificities may be created by junctional diversification alone. 
Summary 
10 ailoreactive cytotoxic T  lymphocytes using REX Ti /3 variable region (V) 1392  ACUTO  ET  AL.  BRIEF  DEFINITIVE  REPORT 
gene segments in  formation of their antigen/major histocompatibility complex 
(MHC) T3-Ti receptor were selected,  cloned, and characterized in an effort to 
examine  the  extent  of receptor  diversity  created  by  this  one  V  gene  family. 
Multiple  and  distinct  class  II as  well  as  class  I  allospecificities  were  generated 
from  the  formation  of different  Ti  13  V  domains.  Five  allospecificities  were 
directed at various class I  epitopes whereas the other five were directed at class 
II MHC gene products. The following conclusions were drawn: (a) Ti/3 V genes 
do not  segregate  into  those  that  encode class  I  and  those  that  encode class  II 
allospecificities; and (b) there is no restriction on the Ti/3 V  gene pool available 
to T4  + vs. T8  + T  lymphocytes. 
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